Michel H Maillard
Overview
Explore the profile of Michel H Maillard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinho-Grueber M, Kapoglou I, Bravo F, Sarraj R, Benz E, Restellini S, et al.
Eur J Gastroenterol Hepatol
. 2022 Nov;
35(1):21-30.
PMID: 36317770
Objectives Of The Study: There is little guidance regarding the impact of alcohol and cannabis on the clinical course of inflammatory bowel disease. The aim of this study was to...
2.
Perrig K, Krupka N, Jordi S, Rossel J, Biedermann L, Greuter T, et al.
Therap Adv Gastroenterol
. 2022 Feb;
15:17562848221074188.
PMID: 35154389
Background: Tumor necrosis factor (TNF) inhibitors have improved treatment of ulcerative colitis (UC), but loss of response remains a frequent problem. The anti-TNF agent, golimumab, was approved in Switzerland for...
3.
Albshesh A, Eder P, Ribaldone D, Oldenburg B, de Boer N, Mantzaris G, et al.
J Crohns Colitis
. 2021 Jul;
16(1):91-97.
PMID: 34274962
Background: Hypogammaglobulinaemia is a disorder characterized by low serum immunoglobulin levels and a high prevalence of gastrointestinal manifestations. In some cases, clinical and endoscopic features are indistinguishable from those of...
4.
Pittet L, Verolet C, Michetti P, Gaillard E, Girardin M, Juillerat P, et al.
Digestion
. 2021 May;
102(6):956-964.
PMID: 33971650
Background: Patients with inflammatory bowel disease (IBD) have a higher risk of infection and are frequently not up to date with their immunizations. Objectives: This study aims to review vaccination...
5.
Santi G, Michetti P, Froehlich F, Rossel J, Pittet V, Maillard M
Inflamm Intest Dis
. 2021 Apr;
6(1):25-31.
PMID: 33850836
Background: Long-standing ulcerative colitis has been associated with an increased risk of colorectal cancer (CRC). Current guidelines recommend endoscopic CRC screening after 8 years of disease duration. The objectives of...
6.
Schreiner P, Mueller N, Fehr J, Maillard M, Brand S, Michetti P, et al.
J Crohns Colitis
. 2020 Jun;
PMID: 32592587
Primary Varicella Zoster virus (VZV) infection results in varicella (chickenpox) while its reactivation results in herpes zoster (HZ; shingles). Patients with Inflammatory Bowel Disease (IBD) are susceptible to complications of...
7.
Restellini S, Buyse S, Godat S, Goossens N, Maillard M
Rev Med Suisse
. 2020 Apr;
16(N° 691-2):845-848.
PMID: 32348050
The current epidemic of SARS-CoV-2 infection poses new challenges in the management of patients with gastrointestinal or liver disease. Consultations with patients with chronic diseases should ideally be done via...
8.
Begka C, Pattaroni C, Mooser C, Nancey S, McCoy K, Velin D, et al.
iScience
. 2020 Mar;
23(3):100891.
PMID: 32114379
Expression of Toll-interacting protein (Tollip), a potent TLR modulator, decreases in patients with inflammatory bowel diseases (IBD), whereas Tollip mice are susceptible to colitis. Tollip expression was shown to be...
9.
Manser C, Maillard M, Rogler G, Schreiner P, Rieder F, Buhler S
Digestion
. 2020 Jan;
101 Suppl 1:58-68.
PMID: 31968344
During the course of disease, a majority of inflammatory bowel disease (IBD) patients requires long-term immunosuppressive therapy with either immunomodulatory agents, biologics, or newer immunosuppressive therapies such as Vedolizumab, a...
10.
Burri E, Maillard M, Schoepfer A, Seibold F, Van Assche G, Riviere P, et al.
Digestion
. 2020 Jan;
101 Suppl 1:2-15.
PMID: 31945767
Background: Patient care in ulcerative colitis (UC) remains challenging despite an array of established treatment options and emerging new therapies. The management of UC therapy should be guided by the...